Luca Cantini
Ancona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
Role of health digital twins in oncology drug development - a primer.
Journal: Frontiers in oncology
Published: May 19, 2026
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 17, 2025
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.
Journal: Journal for immunotherapy of cancer
Published: July 31, 2025
A Decade of Treating ALK-Rearranged Non-Small Cell Lung Cancer in a Lower Middle-Income Country: Changing Patterns and Improving Survival.
Journal: Oncology and therapy
Published: July 16, 2025
Clinically interpretable nomogram combining body composition and clinicopathological features for one year survival prediction in advanced solid tumors.
Journal: Scientific reports
Published: June 20, 2025
Feature Engineering Assessment of Tumor Infiltrating Lymphocytes in Lung Adenocarcinoma.
Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Published: March 05, 2025
What are RECIST 1.1 progressions made of? Variability in double-read oncology trials.
Journal: European radiology
Published: February 12, 2025
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry.
Journal: Journal for immunotherapy of cancer
Published: December 29, 2024
Unraveling the link between cholesterol and immune system in cancer: From biological mechanistic insights to clinical evidence. A narrative review.
Journal: Critical reviews in oncology/hematology
Published: November 26, 2024
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy.
Journal: Immunotherapy
Published: August 06, 2024
Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy.
Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy.
Journal: Frontiers in oncology
Published: July 31, 2024
Last Updated: 09/26/2026